Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials.
Stephen D SilbersteinJoshua M CohenRonghua YangSanjay K GandhiEvelyn DuAdelene E JannMichael J MarmuraPublished in: The journal of headache and pain (2021)
ClinicalTrials.gov identifiers: NCT02629861 (HALO EM) and NCT02621931 (HALO CM).